A night of elegance and commitment. Celebrating 30 years of the Diplomatic Association of Panama in collaboration with Lanco Medical Group. Honoring the charitable work of the ADP and its...
A través de nuestra filial de Suministros Médicos Alcalá Pharma, asistimos a este evento donde mantuvimos reuniones estratégicas con los proveedores más importantes de Asia, Europa y Estados Unidos.
Recently, representatives of Lanco Medical Group, a Colombian pharmaceutical company, expressed their interest in executing projects in the country due to the decrease in crime rates and the increase...
The announcement of TopAlliance Biosciences, a wholly-owned subsidiary of Junshi Biosciences of FDA approval of LOQTORZI™ (toripalimab-tpzi), marks a success in the treatment of nasopharyngeal carcinoma (NPC). This treatment,...
In a significant stride toward advancing healthcare solutions, Lanco Medical Group and Aurobindo, two stalwarts in the medical industry, have joined forces in a groundbreaking partnership. This strategic alliance...
Today, we are thrilled to share the latest milestone in our partnership – the launch of groundbreaking cardiovascular and cardiometabolic products across Central America! Innovation That Inspires: Nobel Pharmaceuticals,...
[Miami, 2023.10.18] – Venipharm,a leading French pharmaceutical company specializing in generics and pharmaceutical development, has announced a groundbreaking strategic partnership with Lanco Medical Group, a renowned player in the...
We are thrilled to announce a groundbreaking partnership that is reshaping the landscape of healthcare in Central America. Through our strategic alliance with Zydus Lifesciences, we are introducing top-tier...
©2023 Lanco Medical Group
Reservados todos los derechos.
